Apr. 14, 2021
Our technology has been published in “Brain”.
Please check the following PDF file.
Photo-oxygenation by a biocompatible catalyst reduces amyloid-β levels in the brains of Alzheimer’s disease model mice
3-11-8 Sendagaya, Shibuya-ku, Tokyo 151-0051 Japan
© 2020. Vermilion Therapeutics Inc. All Rights Reserved.